Search Press releases

Press releases teaser image
24 Sep 2024

UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024

Read More
Press releases teaser image
23 Sep 2024

UCB announces U.S. FDA approvals for BIMZELX[®] (bimekizumab-bkzx) for the treatment of psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis

Read More
Press releases teaser image
9 Sep 2024

New insights highlight unmet needs for people living with Lennox-Gastaut syndrome and significant burden of the disease

Read More
Press releases teaser image
6 Sep 2024

Transparency notification BlackRock, Inc.

Read More
Press releases teaser image
6 Sep 2024

UCB presents new data across expansive epilepsies portfolio at 15th European Epilepsy Congress (EEC)

Read More
Press releases teaser image
5 Sep 2024

Transparency notification BlackRock, Inc.

Read More

Stay up-to-date on the latest news and information from UCB